-+ 0.00%
-+ 0.00%
-+ 0.00%

ADARX PHARMACEUTICALS RECEIVES FDA FAST TRACK DESIGNATION FOR ONVUZOSIRAN FOR THE TREATMENT OF HAE

Reuters·08/24/2026 12:00:39

Please log in to view news